Automated Insulin Delivery (AID) systems automatically adjust insulin delivery to help control blood glucose levels, reduce hypoglycemia, and increase time in range. AID systems are often called hybrid closed loop systems and allow for a complete circle of communication between a continuous glucose monitor (CGM) and insulin Pod/pump.
The global Closed-loop Automated Insulin Delivery (AID) System market size was valued at US$ million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of %during review period.
This report is a detailed and comprehensive analysis for global Closed-loop Automated Insulin Delivery (AID) System market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global Closed-loop Automated Insulin Delivery (AID) System market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
Global Closed-loop Automated Insulin Delivery (AID) System market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
Global Closed-loop Automated Insulin Delivery (AID) System market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
Global Closed-loop Automated Insulin Delivery (AID) System market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Closed-loop Automated Insulin Delivery (AID) System
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Closed-loop Automated Insulin Delivery (AID) System market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Medtronic, Tandem Diabetes Care, Admetsys, Insulet, Defymed, Beta Bionics (iLet), Bigfoot Biomedical, Dexcom, MicroTech Medical (Hangzhou) Co., Ltd., Medtrum, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Closed-loop Automated Insulin Delivery (AID) System market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Hybrid Closed Loop Systems
DIY Closed Loop Systems
Market segment by Application
Children with Type 1 Diabetes
Adults with Type 1 Diabetes
Major players covered
Medtronic
Tandem Diabetes Care
Admetsys
Insulet
Defymed
Beta Bionics (iLet)
Bigfoot Biomedical
Dexcom
MicroTech Medical (Hangzhou) Co., Ltd.
Medtrum
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Closed-loop Automated Insulin Delivery (AID) System product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Closed-loop Automated Insulin Delivery (AID) System, with price, sales quantity, revenue, and global market share of Closed-loop Automated Insulin Delivery (AID) System from 2019 to 2024.
Chapter 3, the Closed-loop Automated Insulin Delivery (AID) System competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Closed-loop Automated Insulin Delivery (AID) System breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Closed-loop Automated Insulin Delivery (AID) System market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Closed-loop Automated Insulin Delivery (AID) System.
Chapter 14 and 15, to describe Closed-loop Automated Insulin Delivery (AID) System sales channel, distributors, customers, research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 Market Overview
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Closed-loop Automated Insulin Delivery (AID) System Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Hybrid Closed Loop Systems
1.3.3 DIY Closed Loop Systems
1.4 Market Analysis by Application
1.4.1 Overview: Global Closed-loop Automated Insulin Delivery (AID) System Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Children with Type 1 Diabetes
1.4.3 Adults with Type 1 Diabetes
1.5 Global Closed-loop Automated Insulin Delivery (AID) System Market Size & Forecast
1.5.1 Global Closed-loop Automated Insulin Delivery (AID) System Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Closed-loop Automated Insulin Delivery (AID) System Sales Quantity (2019-2030)
1.5.3 Global Closed-loop Automated Insulin Delivery (AID) System Average Price (2019-2030)
2 Manufacturers Profiles
2.1 Medtronic
2.1.1 Medtronic Details
2.1.2 Medtronic Major Business
2.1.3 Medtronic Closed-loop Automated Insulin Delivery (AID) System Product and Services
2.1.4 Medtronic Closed-loop Automated Insulin Delivery (AID) System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Medtronic Recent Developments/Updates
2.2 Tandem Diabetes Care
2.2.1 Tandem Diabetes Care Details
2.2.2 Tandem Diabetes Care Major Business
2.2.3 Tandem Diabetes Care Closed-loop Automated Insulin Delivery (AID) System Product and Services
2.2.4 Tandem Diabetes Care Closed-loop Automated Insulin Delivery (AID) System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Tandem Diabetes Care Recent Developments/Updates
2.3 Admetsys
2.3.1 Admetsys Details
2.3.2 Admetsys Major Business
2.3.3 Admetsys Closed-loop Automated Insulin Delivery (AID) System Product and Services
2.3.4 Admetsys Closed-loop Automated Insulin Delivery (AID) System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Admetsys Recent Developments/Updates
2.4 Insulet
2.4.1 Insulet Details
2.4.2 Insulet Major Business
2.4.3 Insulet Closed-loop Automated Insulin Delivery (AID) System Product and Services
2.4.4 Insulet Closed-loop Automated Insulin Delivery (AID) System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Insulet Recent Developments/Updates
2.5 Defymed
2.5.1 Defymed Details
2.5.2 Defymed Major Business
2.5.3 Defymed Closed-loop Automated Insulin Delivery (AID) System Product and Services
2.5.4 Defymed Closed-loop Automated Insulin Delivery (AID) System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Defymed Recent Developments/Updates
2.6 Beta Bionics (iLet)
2.6.1 Beta Bionics (iLet) Details
2.6.2 Beta Bionics (iLet) Major Business
2.6.3 Beta Bionics (iLet) Closed-loop Automated Insulin Delivery (AID) System Product and Services
2.6.4 Beta Bionics (iLet) Closed-loop Automated Insulin Delivery (AID) System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Beta Bionics (iLet) Recent Developments/Updates
2.7 Bigfoot Biomedical
2.7.1 Bigfoot Biomedical Details
2.7.2 Bigfoot Biomedical Major Business
2.7.3 Bigfoot Biomedical Closed-loop Automated Insulin Delivery (AID) System Product and Services
2.7.4 Bigfoot Biomedical Closed-loop Automated Insulin Delivery (AID) System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Bigfoot Biomedical Recent Developments/Updates
2.8 Dexcom
2.8.1 Dexcom Details
2.8.2 Dexcom Major Business
2.8.3 Dexcom Closed-loop Automated Insulin Delivery (AID) System Product and Services
2.8.4 Dexcom Closed-loop Automated Insulin Delivery (AID) System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Dexcom Recent Developments/Updates
2.9 MicroTech Medical (Hangzhou) Co., Ltd.
2.9.1 MicroTech Medical (Hangzhou) Co., Ltd. Details
2.9.2 MicroTech Medical (Hangzhou) Co., Ltd. Major Business
2.9.3 MicroTech Medical (Hangzhou) Co., Ltd. Closed-loop Automated Insulin Delivery (AID) System Product and Services
2.9.4 MicroTech Medical (Hangzhou) Co., Ltd. Closed-loop Automated Insulin Delivery (AID) System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 MicroTech Medical (Hangzhou) Co., Ltd. Recent Developments/Updates
2.10 Medtrum
2.10.1 Medtrum Details
2.10.2 Medtrum Major Business
2.10.3 Medtrum Closed-loop Automated Insulin Delivery (AID) System Product and Services
2.10.4 Medtrum Closed-loop Automated Insulin Delivery (AID) System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Medtrum Recent Developments/Updates
3 Competitive Environment: Closed-loop Automated Insulin Delivery (AID) System by Manufacturer
3.1 Global Closed-loop Automated Insulin Delivery (AID) System Sales Quantity by Manufacturer (2019-2024)
3.2 Global Closed-loop Automated Insulin Delivery (AID) System Revenue by Manufacturer (2019-2024)
3.3 Global Closed-loop Automated Insulin Delivery (AID) System Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Closed-loop Automated Insulin Delivery (AID) System by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Closed-loop Automated Insulin Delivery (AID) System Manufacturer Market Share in 2023
3.4.3 Top 6 Closed-loop Automated Insulin Delivery (AID) System Manufacturer Market Share in 2023
3.5 Closed-loop Automated Insulin Delivery (AID) System Market: Overall Company Footprint Analysis
3.5.1 Closed-loop Automated Insulin Delivery (AID) System Market: Region Footprint
3.5.2 Closed-loop Automated Insulin Delivery (AID) System Market: Company Product Type Footprint
3.5.3 Closed-loop Automated Insulin Delivery (AID) System Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Closed-loop Automated Insulin Delivery (AID) System Market Size by Region
4.1.1 Global Closed-loop Automated Insulin Delivery (AID) System Sales Quantity by Region (2019-2030)
4.1.2 Global Closed-loop Automated Insulin Delivery (AID) System Consumption Value by Region (2019-2030)
4.1.3 Global Closed-loop Automated Insulin Delivery (AID) System Average Price by Region (2019-2030)
4.2 North America Closed-loop Automated Insulin Delivery (AID) System Consumption Value (2019-2030)
4.3 Europe Closed-loop Automated Insulin Delivery (AID) System Consumption Value (2019-2030)
4.4 Asia-Pacific Closed-loop Automated Insulin Delivery (AID) System Consumption Value (2019-2030)
4.5 South America Closed-loop Automated Insulin Delivery (AID) System Consumption Value (2019-2030)
4.6 Middle East & Africa Closed-loop Automated Insulin Delivery (AID) System Consumption Value (2019-2030)
5 Market Segment by Type
5.1 Global Closed-loop Automated Insulin Delivery (AID) System Sales Quantity by Type (2019-2030)
5.2 Global Closed-loop Automated Insulin Delivery (AID) System Consumption Value by Type (2019-2030)
5.3 Global Closed-loop Automated Insulin Delivery (AID) System Average Price by Type (2019-2030)
6 Market Segment by Application
6.1 Global Closed-loop Automated Insulin Delivery (AID) System Sales Quantity by Application (2019-2030)
6.2 Global Closed-loop Automated Insulin Delivery (AID) System Consumption Value by Application (2019-2030)
6.3 Global Closed-loop Automated Insulin Delivery (AID) System Average Price by Application (2019-2030)
7 North America
7.1 North America Closed-loop Automated Insulin Delivery (AID) System Sales Quantity by Type (2019-2030)
7.2 North America Closed-loop Automated Insulin Delivery (AID) System Sales Quantity by Application (2019-2030)
7.3 North America Closed-loop Automated Insulin Delivery (AID) System Market Size by Country
7.3.1 North America Closed-loop Automated Insulin Delivery (AID) System Sales Quantity by Country (2019-2030)
7.3.2 North America Closed-loop Automated Insulin Delivery (AID) System Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 Europe
8.1 Europe Closed-loop Automated Insulin Delivery (AID) System Sales Quantity by Type (2019-2030)
8.2 Europe Closed-loop Automated Insulin Delivery (AID) System Sales Quantity by Application (2019-2030)
8.3 Europe Closed-loop Automated Insulin Delivery (AID) System Market Size by Country
8.3.1 Europe Closed-loop Automated Insulin Delivery (AID) System Sales Quantity by Country (2019-2030)
8.3.2 Europe Closed-loop Automated Insulin Delivery (AID) System Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 Asia-Pacific
9.1 Asia-Pacific Closed-loop Automated Insulin Delivery (AID) System Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Closed-loop Automated Insulin Delivery (AID) System Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Closed-loop Automated Insulin Delivery (AID) System Market Size by Region
9.3.1 Asia-Pacific Closed-loop Automated Insulin Delivery (AID) System Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Closed-loop Automated Insulin Delivery (AID) System Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 South Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 South America
10.1 South America Closed-loop Automated Insulin Delivery (AID) System Sales Quantity by Type (2019-2030)
10.2 South America Closed-loop Automated Insulin Delivery (AID) System Sales Quantity by Application (2019-2030)
10.3 South America Closed-loop Automated Insulin Delivery (AID) System Market Size by Country
10.3.1 South America Closed-loop Automated Insulin Delivery (AID) System Sales Quantity by Country (2019-2030)
10.3.2 South America Closed-loop Automated Insulin Delivery (AID) System Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 Middle East & Africa
11.1 Middle East & Africa Closed-loop Automated Insulin Delivery (AID) System Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Closed-loop Automated Insulin Delivery (AID) System Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Closed-loop Automated Insulin Delivery (AID) System Market Size by Country
11.3.1 Middle East & Africa Closed-loop Automated Insulin Delivery (AID) System Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Closed-loop Automated Insulin Delivery (AID) System Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 Market Dynamics
12.1 Closed-loop Automated Insulin Delivery (AID) System Market Drivers
12.2 Closed-loop Automated Insulin Delivery (AID) System Market Restraints
12.3 Closed-loop Automated Insulin Delivery (AID) System Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
13.1 Raw Material of Closed-loop Automated Insulin Delivery (AID) System and Key Manufacturers
13.2 Manufacturing Costs Percentage of Closed-loop Automated Insulin Delivery (AID) System
13.3 Closed-loop Automated Insulin Delivery (AID) System Production Process
13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Closed-loop Automated Insulin Delivery (AID) System Typical Distributors
14.3 Closed-loop Automated Insulin Delivery (AID) System Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Medtronic
Tandem Diabetes Care
Admetsys
Insulet
Defymed
Beta Bionics (iLet)
Bigfoot Biomedical
Dexcom
MicroTech Medical (Hangzhou) Co., Ltd.
Medtrum
听
听
*If Applicable.
